The Discovery of Molecular Mechanism Counts as a Basic Factor In The Organization of Blood Clot
|
As the increase in blood clots that can affect clotting, one a killer, either slow clotting may make the patient bleed to death.
British experts say the discovery is very important and can contribute to the development of a new treatment for blood diseases.
A
system to connect molecular regulating the process of blood clotting so
that no more than thrombosis rate of not less than justified.
The
Harvard team identified a location on the clotting protein, factor von
Wildrand, featuring improved molecular regulates the size of the
protein, and plays a key role in the effectiveness of its work.
The Von Wildrand factor crucial for the functioning of the circulatory
system of the body, because it controls the balance between blood
clotting and bleeding can be any defect in this factor that leads to
health problems such as bleeding or heart attack.
Dr. Leslie Wong Said, one of the participants in the research: "In the human
body, an enormous capacity to cure itself of the complexities of life
and deterring, and the basis of its response to the damage that his
ability to stop the bleeding, a process known as coagulation. However, the
organization thrombosis is the balance of a complex."
He
says the research team discovered that will help in understanding how
the body's regulation of blood clot formation and may help to know how
that makes some bleeding disorders, such as sickness von Wildrand,
impede the process of regulation of those leading in turn to explore new
ways of diagnosis and treatment.
"The
importance of the study to reveal to us where these sites are important
for the problems of protein that causes hereditary bleeding and tell us
more about how to dismantle the flow of blood to the von Wildrand
factor."
And
for the benefit of the discovery process, "says Professor Lin:" These
findings help us to understand the overlap between the molecular
structure factor von Wildrand and the flow of blood and common diseases,
and will help to develop forms of treatment. "
Professor
Jeremy Pearson, Medical Director, Associate Administrator of the
British Heart Foundation: "allow these researchers to decode the
installation of an important protein plays a crucial role within our
league. This helps us to understand how to govern in the amount of blood
that Inzvha the body after injury, wound with prevents blood from
clotting in the position "error.
He
adds: "The discovery that helps to create more effective medicines for
those suffering from diseases such as von Wildrand and disorders of
blood coagulation (TTP), which does not consider ways to remedy the
current is good enough."
|